Treatment of the Anemia of Progressive Renal Failure with Recombinant Human Erythropoietin
- 20 July 1989
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 321 (3) , 158-163
- https://doi.org/10.1056/nejm198907203210305
Abstract
To examine the effects of erythropoietin on the anemia of chronic renal disease and on the rate of renal deterioration, we administered recombinant human erythropoietin to 17 patients with anemia and progressive renal failure who did not yet require dialysis (serum creatinine level, 353 to 972 μmol per liter [4.0 to 11.0 mg per deciliter]). The dose of erythropoietin (50 to 150 units per kilogram of body weight) was adjusted according to the hematocrit response.This publication has 24 references indexed in Scilit:
- The Effect of Blood Transfusions on the Kidney Function of Chronic Nephritis with AnemiaActa Medica Scandinavica, 2009
- Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.BMJ, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- Hematopoietic inhibitors in chronic renal failure: Lack of in vitro specificityKidney International, 1986
- Anemia of end-stage renal disease (ESRD)Kidney International, 1985
- The Effect of a Keto Acid–Amino Acid Supplement to a Restricted Diet on the Progression of Chronic Renal FailureNew England Journal of Medicine, 1984
- Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiencyKidney International, 1984
- Effects of hematocrit on renal hemodynamics and sodium excretion in hydropenic and volume-expanded dogsJournal of Clinical Investigation, 1970
- Some Therapeutic Approaches to Chronic Renal InsufficiencyAnnual Review of Medicine, 1965